Arcadia Biosciences, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 30 →InsidersNo open-market buys or sales.→HoldersCitadel 1.1%StoneX 0.6%Geode 0.7%→Financing →PeersClosest companies: SRFM, EMPD, ISSC→
From the filings
Figures
- Revenue
- $4.7Mlast 12 months
- Net income
- −$11.1Mlast 12 months
- Operating cash flow
- −$4.2Mlast 12 months
- Cash and equivalents
- $4.2Mat the last balance sheet
- Shares outstanding
- 2.2M shareson issue